Philip R. Tracy
Director/Board Member bij Viamet Pharmaceuticals Corp.
Profiel
Mr. Phil R.
Tracy is a Principal at Intersouth Partners.
He joined Intersouth Partners in 1997.
He was previously employed as President & Chief Executive Officer by Burroughs Wellcome from 1974 to 1995.
Earlier, most of his career was spent at Burroughs Wellcome Co., a major research-based pharmaceutical company.
At Burroughs Wellcome, he served as President and CEO from 1989 until the company's merger with Glaxo in 1995.
Mr. Tracy is Chairman at Alimera Sciences, Inc. since 2004, and Counsel at Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan LLP.
He is on the Board of Directors at Argos Therapeutics, Inc. since 2004.
Mr. Tracy received a B.A.
from the University of Nebraska and a J.D.
and L.L.B.
from George Washington University.
Actieve functies van Philip R. Tracy
| Bedrijven | Functie | Begin |
|---|---|---|
Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan LLP
 Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan LLP Miscellaneous Commercial ServicesCommercial Services Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan LLP provides legal services. The private company is based in Raleigh, NC. | General Counsel | 06-01-2014 |
| Intersouth Associates V LLC | Director/Board Member | - |
| Intersouth Associates IV LLC | Director/Board Member | - |
Viamet Pharmaceuticals Corp.
 Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | Director/Board Member | 01-01-2015 |
Eerdere bekende functies van Philip R. Tracy
| Bedrijven | Functie | Einde |
|---|---|---|
| ALIMERA SCIENCES, INC. | Chairman | 06-05-2015 |
| Burroughs Wellcome | Chief Executive Officer | 01-01-1995 |
Viamet Pharmaceuticals, Inc.
 Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals, Inc. discovers and develops inhibitors of validated metalloenzymes. The firm's clinical portfolio includes novel agents to treat both chronic and life threatening fungal infections. It also leverage our metalloenzyme expertise in other therapeutic areas including oncology and orphan diseases. The company was founded by Thomas V. O’Halloran and Holden H. Thorp on August 18, 2005 and is headquartered in Durham, NC. | Director/Board Member | - |
The Burroughs Wellcome Fund
 The Burroughs Wellcome Fund Investment Trusts/Mutual FundsMiscellaneous The Burroughs Wellcome Fund is a private foundation located in Research Triangle Park, NC. The private company's mission is to serve and strengthen society by nurturing a diverse group of leaders in biomedical sciences to improve human health through education and powering discovery in frontiers of greatest need. The CEO of the company is Louis J. Muglia. | Director/Board Member | - |
Intersouth Partners
 Intersouth Partners Investment ManagersFinance Intersouth Partners (Intersouth Partners) is a venture capital firm founded in 1985 by Dennis Dougherty and Roy Rodwell. The firm is headquartered in Durham, North Carolina. | Private Equity Investor | - |
Opleiding van Philip R. Tracy
| University of Nebraska | Undergraduate Degree |
| George Washington University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ALIMERA SCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 9 |
|---|---|
Viamet Pharmaceuticals, Inc.
Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals, Inc. discovers and develops inhibitors of validated metalloenzymes. The firm's clinical portfolio includes novel agents to treat both chronic and life threatening fungal infections. It also leverage our metalloenzyme expertise in other therapeutic areas including oncology and orphan diseases. The company was founded by Thomas V. O’Halloran and Holden H. Thorp on August 18, 2005 and is headquartered in Durham, NC. | Health Technology |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | Health Technology |
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan LLP
Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan LLP Miscellaneous Commercial ServicesCommercial Services Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan LLP provides legal services. The private company is based in Raleigh, NC. | Commercial Services |
Intersouth Partners
Intersouth Partners Investment ManagersFinance Intersouth Partners (Intersouth Partners) is a venture capital firm founded in 1985 by Dennis Dougherty and Roy Rodwell. The firm is headquartered in Durham, North Carolina. | Finance |
The Burroughs Wellcome Fund
The Burroughs Wellcome Fund Investment Trusts/Mutual FundsMiscellaneous The Burroughs Wellcome Fund is a private foundation located in Research Triangle Park, NC. The private company's mission is to serve and strengthen society by nurturing a diverse group of leaders in biomedical sciences to improve human health through education and powering discovery in frontiers of greatest need. The CEO of the company is Louis J. Muglia. | Miscellaneous |
| Intersouth Associates IV LLC | |
| Intersouth Associates V LLC | |
| Burroughs Wellcome |
